By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content. Working in isolation due to regulatory firewalls, these ...

Background The decision as to whether or not an athlete is ready to return to sport (RTS) after ACL reconstruction is difficult as the commonly used RTS criteria have not been validated. Purpose To ...

The FDA will begin notifying physicians of an apparent risk for autism in children who were exposed to acetaminophen, the main ingredient in Tylenol, during pregnancy, according to an HHS press ...